Curcumin to Prevent Complications After Elective Abdominal Aortic Aneurysm (AAA) Repair

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 606 participants.

Also called NCT01225094

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 606 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01225094
Other papers using this trial's data
  • Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2018-10-29 DOI, PubMed 30373740, PMC6205831 PubMed links an erratum for this paper. Erratum: PMID 30510051 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01225094. Randomized; quadruple masking; primary purpose prevention. Start 2011-11 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Curcumin to Prevent Complications After Elective Abdominal Aortic Aneurysm (AAA) Repair
Condition
Abdominal Aortic Aneurysm
Intervention (Drug)
curcumin
Intervention (Other)
placebo
Lead sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)

Record details

Record id
cardio:ct-nct01225094
Content hash
15b21e7f9d3478920d9442617973f7ad370c61b620fecc28e318f366d3ce6f48